NEW YORK (GenomeWeb) – Medicare contractor Palmetto GBA today issued its final local coverage determination for CareDx's cfDNA-based organ transplant test AlloSure.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.